Iecoris cancer et Hepatitis B
In Africa, hepatitis B maxima causa est cancri hepatis, ac 80% hepatitis cancri hepatis causa. Nulla certa curatio vel medela hepatitis acutis B, et maxime adultis longis morbis proficit. Diagnosis longi hepatitis B transiens certum sanguinem titulum probat, quod post 6 menses ultimos vel plures post contagionem initialem. Etsi vaccinatio hepatitis B contagione impedire potest, nonnulli pueri hepatitis B a nativitate vel minus quam quinque annos nati sunt infecti. Infectiones chronicae sunt propriae dolor abdominis, oculi lutei, urina obscura, vel abnormes iecoris probat, sed in quibusdam non possunt esse indicia.
The main problem with chronic hepatitis B is the risk of developing cirrhosis and / or iecoris cancer. For those with chronic infections, taking medicine once a day can prevent the virus from multiplying. When the virus stops growing, the risk of liver cirrhosis and liver cancer is reduced. Hepatitis B can be prevented by vaccination and has been included as part of the Kenya Expanded Immunization Program (KEPI). Newborns need to be vaccinated at 6 weeks, 10 weeks and 14 weeks.
Adultae lacus tres injectiones intra sex menses complentur. Si probatio sanguinis ostendit immunitatem hepatitis B non esse in gradu requisito, cursus dosis opus est. Aegris, qui plenam dosem recipiunt, vaccinum efficaciter impedire potest contagione hepatitis, rate efficax 80% ad 100% est.
https://www.nation.co.ke/health/Fight-hepatitis-B-to-prevent-liver-cirrhosis-and-cancer/3476990-4763768-v0ltkh/index.html
